Projects per year
Personal profile
Area of Expertise
Dr. Fling is board certified in Allergy/Immunology and Pediatrics with over thirty years of experience caring for adults, children, and infants. His main focus is the care and management of individuals suffering from allergies and asthma. He uses evidence-based practice for the diagnoses and treatment strategies, along with patient input to create the optimal treatment plan. In addition to clinical practice, Dr. Fling has been involved as principal investigator in multiple research studies and has a special interest in the development of new vaccines. He is a member of American Academy of Allergy, Asthma, and Immunology, Tarrant County Medical Society, and a fellow of the American Academy of Pediatrics.
Education/Academic qualification
BS in Biology, Southwest Texas State University
MD, University of Texas Health Science Center at San Antonio
Fingerprint
Dive into the research topics where John Fling is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Research Output
- 247 Citations
- 7 h-Index
- 10 Article
-
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study
Klein, N. P., Abu-Elyazeed, R., Povey, M., Macias Parra, M., Diez-Domingo, J., Ahonen, A., Korhonen, T., Tinoco, J. C., Weiner, L., Marshall, G. S., Silas, P. E., Sarpong, K. O., Ramsey, K. P., Fling, J. A., Speicher, D., Campos, M., Munjal, I., Peltier, C., Vesikari, T., Baccarini, C. & 4 others, , 30 Apr 2020, In : Journal of the Pediatric Infectious Diseases Society. 9, 2, p. 194-201 8 p.Research output: Contribution to journal › Article
Open Access2 Scopus citations -
Immunogenicity and safety of an MF59-adjuvanted quadrivalent seasonal influenza vaccine in young children at high risk of influenza-associated complications: A Phase III, Randomized, observer-blind, multicenter clinical trial
Esposito, S., Fling, J., Chokephaibulkit, K., De Bruijn, M., Oberye, J., Zhang, B., Vossen, J., Heijnen, E. & Smolenov, I., 1 Aug 2020, In : Pediatric Infectious Disease Journal. 39, 8, p. E185-E191Research output: Contribution to journal › Article
Open Access -
Lot-to-lot consistency, safety, tolerability and immunogenicity of an investigational hexavalent vaccine in US infants
Block, S. L., Klein, N. P., Sarpong, K., Russell, S., Fling, J., Petrecz, M., Flores, S., Xu, J., Liu, G., Stek, J. E., Foglia, G. & Lee, A. W., 2017, In : Pediatric Infectious Disease Journal. 36, 2, p. 202-208 7 p.Research output: Contribution to journal › Article
8 Scopus citations -
Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age
Gorse, G. J., Falsey, A. R., Fling, J. A., Poling, T. L., Strout, C. B. & Tsang, P. H., 1 May 2013, In : Vaccine. 31, 19, p. 2358-2365 8 p.Research output: Contribution to journal › Article
25 Scopus citations -
Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated by candidiasis
Spraker, M. K., Gisoldi, E. M., Siegfried, E. C., Fling, J. A., De Espinosa, Z. D., Quiring, J. N. & Zangrilli, S. G., 1 Feb 2006, In : Cutis. 77, 2, p. 113-120 8 p.Research output: Contribution to journal › Article
20 Scopus citations